approval · primary record
TILDRAKIZUMAB-ASMN
FDA · BLA · 2026-07-16
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2026-07-16 |
| Brand | ILUMYA |
| Sponsor | SUN PHARMA GLOBAL |
| Route | INJECTION |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T10:40:06.837Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:TILDRAKIZUMAB-ASMN:2026-07-16
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Tildrakizumab-Asmn · compound